BRD8518
BRD8518 is a PCSK9 inhibitor (EC50=0.23 μM) . BRD8518 lowers blood lipids by upregulating LDLR expression and stimulating LDL uptake. BRD8518 can be used in the study of cardiovascular diseases[1].
Product Specifications
CAS Number
1565828-01-4
UNSPSC
12352005
Target
LDLR; PCSK9
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Field of Research
Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/brd8518.html
Smiles
O=C(NC1=CC=C2C(C(N(C)[C@H]3CC[C@@H](CC(NC4CC(C=CC=C5)=C5C4)=O)O[C@H]3CO2)=O)=C1)C6=CC=C(C(F)(F)F)C=C6
Molecular Formula
C33H32F3N3O5
Molecular Weight
607.62
References & Citations
[1]Xuhui Bao, et al. "Targeting proprotein convertase subtilisin/kexin type 9 (PCSK9) : from bench to bedside." Signal Transduction and Targeted Therapy 9.1 (2024) : 13.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
NBP3-05967G 0.1 mL
Mouse Monoclonal Flagellin Antibody (06) [DyLight 488]
Sign In for Pricing
View Details A0650-01D-ML550 100 µL
ACK1, NT (Tyrosine Kinase Non-receptor Protein 2, Activated CDC42 Kinase 1, ACK-1, TNK2) (MaxLight 550) discontinued
Sign In for Pricing
View Details 